LOS ANGELES — Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, MD, said during Cornea Day at the American Society of Cataract and Refractive Surgery meeting.
Holland, a professor of ophthalmology at the University of Cincinnati and director of cornea and external disease at the Cincinnati Eye Institute, presented the inaugural Holland Lecture, the first named lecture for the subspecialty day.
Penetrating keratoplasty is the most common surgery performed for total limbal deficiency; however, it is never